INM — InMed Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for InMed Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2019 June 30th	R2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13.8	5.85	7.41	6.22	8.96
Net Total Accounts Receivable
Net Total Receivables	0.065	0.045	0.012	0.088	0.26
Total Inventory
Prepaid Expenses
Total Current Assets	14.2	6.31	8.38	9.6	11.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.043	0.403	0.327	0.904	0.723
Net Intangible Assets
Other Long Term Assets
Total Assets	15.1	7.8	9.78	12.8	14.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.19	1.68	2.22	3.32	2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.19	1.92	2.4	3.71	2.02
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.9	5.88	7.38	9.08	12.1
Total Liabilities & Shareholders' Equity	15.1	7.8	9.78	12.8	14.1
Total Common Shares Outstanding